IBDEI0A2 ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13397,1,1,0)
 ;;=1^560.9
 ;;^UTILITY(U,$J,358.3,13397,1,2,0)
 ;;=2^BOWEL OBSTRUCTION
 ;;^UTILITY(U,$J,358.3,13397,2)
 ;;=^64849
 ;;^UTILITY(U,$J,358.3,13398,0)
 ;;=576.1^^69^751^5
 ;;^UTILITY(U,$J,358.3,13398,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13398,1,1,0)
 ;;=1^576.1
 ;;^UTILITY(U,$J,358.3,13398,1,2,0)
 ;;=2^CHOLANGITIS
 ;;^UTILITY(U,$J,358.3,13398,2)
 ;;=^23291
 ;;^UTILITY(U,$J,358.3,13399,0)
 ;;=574.70^^69^751^6
 ;;^UTILITY(U,$J,358.3,13399,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13399,1,1,0)
 ;;=1^574.70
 ;;^UTILITY(U,$J,358.3,13399,1,2,0)
 ;;=2^CHOLECYSTITIS W/CAL GB & BD
 ;;^UTILITY(U,$J,358.3,13399,2)
 ;;=^304314
 ;;^UTILITY(U,$J,358.3,13400,0)
 ;;=571.2^^69^751^7
 ;;^UTILITY(U,$J,358.3,13400,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13400,1,1,0)
 ;;=1^571.2
 ;;^UTILITY(U,$J,358.3,13400,1,2,0)
 ;;=2^CIRRHOSIS,ALCOHOLIC
 ;;^UTILITY(U,$J,358.3,13400,2)
 ;;=^71505
 ;;^UTILITY(U,$J,358.3,13401,0)
 ;;=571.5^^69^751^8
 ;;^UTILITY(U,$J,358.3,13401,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13401,1,1,0)
 ;;=1^571.5
 ;;^UTILITY(U,$J,358.3,13401,1,2,0)
 ;;=2^CIRRHOSIS,NON-ALCOHOLIC
 ;;^UTILITY(U,$J,358.3,13401,2)
 ;;=^24731
 ;;^UTILITY(U,$J,358.3,13402,0)
 ;;=555.9^^69^751^9
 ;;^UTILITY(U,$J,358.3,13402,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13402,1,1,0)
 ;;=1^555.9
 ;;^UTILITY(U,$J,358.3,13402,1,2,0)
 ;;=2^CROHN'S DISEASE
 ;;^UTILITY(U,$J,358.3,13402,2)
 ;;=^29356
 ;;^UTILITY(U,$J,358.3,13403,0)
 ;;=578.9^^69^751^10
 ;;^UTILITY(U,$J,358.3,13403,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13403,1,1,0)
 ;;=1^578.9
 ;;^UTILITY(U,$J,358.3,13403,1,2,0)
 ;;=2^GASTROINTEST HEMORR NOS
 ;;^UTILITY(U,$J,358.3,13403,2)
 ;;=^49525
 ;;^UTILITY(U,$J,358.3,13404,0)
 ;;=572.2^^69^751^11
 ;;^UTILITY(U,$J,358.3,13404,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13404,1,1,0)
 ;;=1^572.2
 ;;^UTILITY(U,$J,358.3,13404,1,2,0)
 ;;=2^HEPATIC ENCEPHALOPATHY
 ;;^UTILITY(U,$J,358.3,13404,2)
 ;;=^338527
 ;;^UTILITY(U,$J,358.3,13405,0)
 ;;=573.4^^69^751^12
 ;;^UTILITY(U,$J,358.3,13405,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13405,1,1,0)
 ;;=1^573.4
 ;;^UTILITY(U,$J,358.3,13405,1,2,0)
 ;;=2^HEPATIC INFARCTION
 ;;^UTILITY(U,$J,358.3,13405,2)
 ;;=^276862
 ;;^UTILITY(U,$J,358.3,13406,0)
 ;;=570.^^69^751^13
 ;;^UTILITY(U,$J,358.3,13406,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13406,1,1,0)
 ;;=1^570.
 ;;^UTILITY(U,$J,358.3,13406,1,2,0)
 ;;=2^HEPATIC NECROSIS
 ;;^UTILITY(U,$J,358.3,13406,2)
 ;;=^2603
 ;;^UTILITY(U,$J,358.3,13407,0)
 ;;=572.4^^69^751^14
 ;;^UTILITY(U,$J,358.3,13407,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13407,1,1,0)
 ;;=1^572.4
 ;;^UTILITY(U,$J,358.3,13407,1,2,0)
 ;;=2^HEPATORENAL SYNDROME
 ;;^UTILITY(U,$J,358.3,13407,2)
 ;;=^56497
 ;;^UTILITY(U,$J,358.3,13408,0)
 ;;=557.9^^69^751^15
 ;;^UTILITY(U,$J,358.3,13408,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13408,1,1,0)
 ;;=1^557.9
 ;;^UTILITY(U,$J,358.3,13408,1,2,0)
 ;;=2^INTEST ISCHEMIA & INFARCTION
 ;;^UTILITY(U,$J,358.3,13408,2)
 ;;=^270252
 ;;^UTILITY(U,$J,358.3,13409,0)
 ;;=577.0^^69^751^16
 ;;^UTILITY(U,$J,358.3,13409,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13409,1,1,0)
 ;;=1^577.0
 ;;^UTILITY(U,$J,358.3,13409,1,2,0)
 ;;=2^PANCREATITIS
 ;;^UTILITY(U,$J,358.3,13409,2)
 ;;=^2643
 ;;^UTILITY(U,$J,358.3,13410,0)
 ;;=567.9^^69^751^17
 ;;^UTILITY(U,$J,358.3,13410,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13410,1,1,0)
 ;;=1^567.9
 ;;^UTILITY(U,$J,358.3,13410,1,2,0)
 ;;=2^PERITONITIS NOS
 ;;^UTILITY(U,$J,358.3,13410,2)
 ;;=^92323
 ;;^UTILITY(U,$J,358.3,13411,0)
 ;;=452.^^69^751^18
 ;;^UTILITY(U,$J,358.3,13411,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13411,1,1,0)
 ;;=1^452.
 ;;^UTILITY(U,$J,358.3,13411,1,2,0)
 ;;=2^PORTAL VEIN THROMBOSIS
 ;;^UTILITY(U,$J,358.3,13411,2)
 ;;=^269815
 ;;^UTILITY(U,$J,358.3,13412,0)
 ;;=556.9^^69^751^19
 ;;^UTILITY(U,$J,358.3,13412,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13412,1,1,0)
 ;;=1^556.9
 ;;^UTILITY(U,$J,358.3,13412,1,2,0)
 ;;=2^ULCERATIVE COLITIS
 ;;^UTILITY(U,$J,358.3,13412,2)
 ;;=^26044
 ;;^UTILITY(U,$J,358.3,13413,0)
 ;;=569.9^^69^751^20
 ;;^UTILITY(U,$J,358.3,13413,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13413,1,1,0)
 ;;=1^569.9
 ;;^UTILITY(U,$J,358.3,13413,1,2,0)
 ;;=2^OTHER INTESTINAL COND
 ;;^UTILITY(U,$J,358.3,13413,2)
 ;;=^123842
 ;;^UTILITY(U,$J,358.3,13414,0)
 ;;=573.9^^69^751^21
 ;;^UTILITY(U,$J,358.3,13414,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13414,1,1,0)
 ;;=1^573.9
 ;;^UTILITY(U,$J,358.3,13414,1,2,0)
 ;;=2^OTHER LIVER DISEASE
 ;;^UTILITY(U,$J,358.3,13414,2)
 ;;=^123854
 ;;^UTILITY(U,$J,358.3,13415,0)
 ;;=580.9^^69^752^1
 ;;^UTILITY(U,$J,358.3,13415,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13415,1,1,0)
 ;;=1^580.9
 ;;^UTILITY(U,$J,358.3,13415,1,2,0)
 ;;=2^ACUTE GLOMERULONEPHRITIS
 ;;^UTILITY(U,$J,358.3,13415,2)
 ;;=^270342
 ;;^UTILITY(U,$J,358.3,13416,0)
 ;;=584.9^^69^752^2
 ;;^UTILITY(U,$J,358.3,13416,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13416,1,1,0)
 ;;=1^584.9
 ;;^UTILITY(U,$J,358.3,13416,1,2,0)
 ;;=2^ACUTE RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,13416,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,13417,0)
 ;;=582.9^^69^752^3
 ;;^UTILITY(U,$J,358.3,13417,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13417,1,1,0)
 ;;=1^582.9
 ;;^UTILITY(U,$J,358.3,13417,1,2,0)
 ;;=2^CHRONIC GLOMERULONEPHRITIS
 ;;^UTILITY(U,$J,358.3,13417,2)
 ;;=^270351
 ;;^UTILITY(U,$J,358.3,13418,0)
 ;;=585.9^^69^752^4
 ;;^UTILITY(U,$J,358.3,13418,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13418,1,1,0)
 ;;=1^585.9
 ;;^UTILITY(U,$J,358.3,13418,1,2,0)
 ;;=2^CHRONIC KIDNEY DISEASE
 ;;^UTILITY(U,$J,358.3,13418,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,13419,0)
 ;;=586.^^69^752^5
 ;;^UTILITY(U,$J,358.3,13419,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13419,1,1,0)
 ;;=1^586.
 ;;^UTILITY(U,$J,358.3,13419,1,2,0)
 ;;=2^OTHER RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,13419,2)
 ;;=^104733
 ;;^UTILITY(U,$J,358.3,13420,0)
 ;;=694.9^^69^753^1
 ;;^UTILITY(U,$J,358.3,13420,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13420,1,1,0)
 ;;=1^694.9
 ;;^UTILITY(U,$J,358.3,13420,1,2,0)
 ;;=2^BULLOUS DERMATOSES NOS
 ;;^UTILITY(U,$J,358.3,13420,2)
 ;;=^187900
 ;;^UTILITY(U,$J,358.3,13421,0)
 ;;=695.10^^69^753^2
 ;;^UTILITY(U,$J,358.3,13421,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13421,1,1,0)
 ;;=1^695.10
 ;;^UTILITY(U,$J,358.3,13421,1,2,0)
 ;;=2^ERYTHEMA MULTIFORME NOS
 ;;^UTILITY(U,$J,358.3,13421,2)
 ;;=^336759
 ;;^UTILITY(U,$J,358.3,13422,0)
 ;;=696.1^^69^753^3
 ;;^UTILITY(U,$J,358.3,13422,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13422,1,1,0)
 ;;=1^696.1
 ;;^UTILITY(U,$J,358.3,13422,1,2,0)
 ;;=2^PSORIASIS
 ;;^UTILITY(U,$J,358.3,13422,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,13423,0)
 ;;=695.81^^69^753^4
 ;;^UTILITY(U,$J,358.3,13423,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13423,1,1,0)
 ;;=1^695.81
 ;;^UTILITY(U,$J,358.3,13423,1,2,0)
 ;;=2^STAPHLYCOCCAL SCALED SKIN SYND
 ;;^UTILITY(U,$J,358.3,13423,2)
 ;;=^113858
 ;;^UTILITY(U,$J,358.3,13424,0)
 ;;=695.13^^69^753^5
 ;;^UTILITY(U,$J,358.3,13424,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13424,1,1,0)
 ;;=1^695.13
 ;;^UTILITY(U,$J,358.3,13424,1,2,0)
 ;;=2^STEVENS-JOHNSON SYNDROME
 ;;^UTILITY(U,$J,358.3,13424,2)
 ;;=^336636
 ;;^UTILITY(U,$J,358.3,13425,0)
 ;;=695.15^^69^753^6
 ;;^UTILITY(U,$J,358.3,13425,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13425,1,1,0)
 ;;=1^695.15
 ;;^UTILITY(U,$J,358.3,13425,1,2,0)
 ;;=2^TOXIC EPIDRML NECROLYSIS
 ;;^UTILITY(U,$J,358.3,13425,2)
 ;;=^336638
 ;;^UTILITY(U,$J,358.3,13426,0)
 ;;=695.9^^69^753^7
 ;;^UTILITY(U,$J,358.3,13426,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13426,1,1,0)
 ;;=1^695.9
 ;;^UTILITY(U,$J,358.3,13426,1,2,0)
 ;;=2^OTHER ERYTHEMATOUS SKIN COND
 ;;^UTILITY(U,$J,358.3,13426,2)
 ;;=^123902
 ;;^UTILITY(U,$J,358.3,13427,0)
 ;;=441.9^^69^754^2
 ;;^UTILITY(U,$J,358.3,13427,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13427,1,1,0)
 ;;=1^441.9
 ;;^UTILITY(U,$J,358.3,13427,1,2,0)
 ;;=2^ANEURYSM,AORTIC W/O RUPTURE
 ;;^UTILITY(U,$J,358.3,13427,2)
 ;;=^9277
 ;;^UTILITY(U,$J,358.3,13428,0)
 ;;=442.9^^69^754^3
 ;;^UTILITY(U,$J,358.3,13428,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13428,1,1,0)
 ;;=1^442.9
 ;;^UTILITY(U,$J,358.3,13428,1,2,0)
 ;;=2^ANEURYSM,NON-AORTIC
 ;;^UTILITY(U,$J,358.3,13428,2)
 ;;=^7390
 ;;^UTILITY(U,$J,358.3,13429,0)
 ;;=710.3^^69^754^4
 ;;^UTILITY(U,$J,358.3,13429,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13429,1,1,0)
 ;;=1^710.3
 ;;^UTILITY(U,$J,358.3,13429,1,2,0)
 ;;=2^DERMATOMYOSITIS
 ;;^UTILITY(U,$J,358.3,13429,2)
 ;;=^33162
 ;;^UTILITY(U,$J,358.3,13430,0)
 ;;=446.5^^69^754^5
 ;;^UTILITY(U,$J,358.3,13430,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13430,1,1,0)
 ;;=1^446.5
 ;;^UTILITY(U,$J,358.3,13430,1,2,0)
 ;;=2^GIANT CELL ARTERITIS
 ;;^UTILITY(U,$J,358.3,13430,2)
 ;;=^117658
 ;;^UTILITY(U,$J,358.3,13431,0)
 ;;=446.20^^69^754^6
 ;;^UTILITY(U,$J,358.3,13431,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13431,1,1,0)
 ;;=1^446.20
 ;;^UTILITY(U,$J,358.3,13431,1,2,0)
 ;;=2^HYPERSENSITIVITY ANGIITIS, UNS
 ;;^UTILITY(U,$J,358.3,13431,2)
 ;;=^60279
 ;;^UTILITY(U,$J,358.3,13432,0)
 ;;=446.3^^69^754^7
 ;;^UTILITY(U,$J,358.3,13432,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13432,1,1,0)
 ;;=1^446.3
 ;;^UTILITY(U,$J,358.3,13432,1,2,0)
 ;;=2^LETHAL MIDLINE GRANULOMA
 ;;^UTILITY(U,$J,358.3,13432,2)
 ;;=^52905
 ;;^UTILITY(U,$J,358.3,13433,0)
 ;;=446.1^^69^754^8
 ;;^UTILITY(U,$J,358.3,13433,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13433,1,1,0)
 ;;=1^446.1
 ;;^UTILITY(U,$J,358.3,13433,1,2,0)
 ;;=2^MUCOCUTANEOUS LYMPH SYND (MCLS)
 ;;^UTILITY(U,$J,358.3,13433,2)
 ;;=^79494
 ;;^UTILITY(U,$J,358.3,13434,0)
 ;;=443.9^^69^754^12
 ;;^UTILITY(U,$J,358.3,13434,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13434,1,1,0)
 ;;=1^443.9
 ;;^UTILITY(U,$J,358.3,13434,1,2,0)
 ;;=2^PERIPH VASCULAR DIS NOS
 ;;^UTILITY(U,$J,358.3,13434,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,13435,0)
 ;;=446.0^^69^754^13
